PCBP4 Antibody, FITC conjugated
-
中文名稱：PCBP4兔多克隆抗體, FITC偶聯(lián)
-
貨號(hào)：CSB-PA017521LC01HU
-
規(guī)格：￥880
-
其他：
產(chǎn)品詳情
-
產(chǎn)品名稱：Rabbit anti-Homo sapiens (Human) PCBP4 Polyclonal antibody
-
Uniprot No.：
-
基因名：PCBP4
-
別名：Alpha CP4 antibody; Alpha-CP4 antibody; LIP4 antibody; LYST interacting protein antibody; MCG10 antibody; PCBP4 antibody; PCBP4_HUMAN antibody; poly(rC) binding protein 4 antibody; Poly(rC)-binding protein 4 antibody; rCbinding protein 4 antibody; RNA binding protein MCG10 antibody
-
宿主：Rabbit
-
反應(yīng)種屬：Human
-
免疫原：Recombinant Human Poly(rC)-binding protein 4 protein (1-150AA)
-
免疫原種屬：Homo sapiens (Human)
-
標(biāo)記方式：FITC
-
克隆類型：Polyclonal
-
抗體亞型：IgG
-
純化方式：Antigen Affinity Purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
產(chǎn)品提供形式：Liquid
-
儲(chǔ)存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產(chǎn)品評(píng)價(jià)
相關(guān)產(chǎn)品
靶點(diǎn)詳情
-
功能：Single-stranded nucleic acid binding protein that binds preferentially to oligo dC.
-
基因功能參考文獻(xiàn)：
- PCBP4 plays important roles in the induction of cisplatin resistance in human maxillary cancers. PMID: 26196957
- expression of alpha CP-4 can inhibit proliferation and tumorigenesis of lung cancer cells, both in vivo and in vitro, by delaying the progression of the cell cycle PMID: 17973258
-
亞細(xì)胞定位：Cytoplasm.
-
數(shù)據(jù)庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
